Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers

NCT02130661 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Rilapladib 25 mg
DRUG: Rilapladib 250 mg
DRUG: Itraconazole

Sponsor

GlaxoSmithKline